![Louis Brenner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louis Brenner
Corporate Officer/Principal bei
Harvard University
Profil
Louis Brenner is currently a Lecturer at Harvard University.
Formerly, Dr. Brenner was President, Chief Executive Officer & Director at Hopewell Therapeutics, Inc. from 2022 to 2024, and held the same titles at Allena Pharmaceuticals, Inc. from 2019 to 2022.
Other former roles include Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. (2014-2015), Chief Medical Officer & Senior Vice President at Radius Health, Inc. (2012-2014), Senior Vice President at AMAG Pharmaceuticals, Inc. (2006-2010), Senior Director-Business Development-Renal Unit at Genzyme Corp.
(2002-2006), and Director positions at PLC Medical Systems, Inc. and Goldfinch Bio, Inc. Education includes a doctorate from Duke University (1996), an undergraduate degree from Yale University (1992), and an MBA from Harvard Business School (2002).
Aktive Positionen von Louis Brenner
| Unternehmen | Position | Beginn |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Louis Brenner
| Unternehmen | Position | Ende |
|---|---|---|
Hopewell Therapeutics, Inc.
 Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Vorstandsvorsitzender | 01.06.2024 |
| ALLENA PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 02.09.2022 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2015 |
| RADIUS HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2014 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.12.2010 |
Ausbildung von Louis Brenner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PLC Medical Systems, Inc.
 PLC Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales medical devices | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Hopewell Therapeutics, Inc.
Hopewell Therapeutics, Inc. BiotechnologyHealth Technology Develops novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy & gene editing | Health Technology |
